Cysticercosis of the central nervous system: how should it be managed?

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMC 3272367)

Published in Curr Opin Infect Dis on October 01, 2011

Authors

Hector H Garcia1, Armando E Gonzalez, Robert H Gilman

Author Affiliations

1: Department of Microbiology, Center for Global Health - Tumbes, Universidad Peruana Cayetano Heredia, Lima, Peru. hgarcia@jhsph.edu

Articles citing this

Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis (2014) 4.64

Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011. PLoS One (2013) 1.16

The impact of neurocysticercosis in california: a review of hospitalized cases. PLoS Negl Trop Dis (2012) 1.09

Neglected parasitic infections in the United States: cysticercosis. Am J Trop Med Hyg (2014) 1.01

Evans blue staining reveals vascular leakage associated with focal areas of host-parasite interaction in brains of pigs infected with Taenia solium. PLoS One (2014) 0.86

Infectious Diseases of Poverty in Children: A Tale of Two Worlds. Pediatr Clin North Am (2016) 0.85

Post-treatment vascular leakage and inflammatory responses around brain cysts in porcine neurocysticercosis. PLoS Negl Trop Dis (2015) 0.83

Genome analysis of Excretory/Secretory proteins in Taenia solium reveals their Abundance of Antigenic Regions (AAR). Sci Rep (2015) 0.81

Current status and future perspectives on the medical treatment of neurocysticercosis. Pathog Glob Health (2012) 0.80

Managing neurocysticercosis: challenges and solutions. Int J Gen Med (2015) 0.79

Molecular Cloning of a cDNA Encoding for Taenia solium TATA-Box Binding Protein 1 (TsTBP1) and Study of Its Interactions with the TATA-Box of Actin 5 and Typical 2-Cys Peroxiredoxin Genes. PLoS One (2015) 0.75

Articles cited by this

A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med (2004) 5.75

Neurocysticercosis: updated concepts about an old disease. Lancet Neurol (2005) 5.37

Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology (1992) 2.89

A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis (2010) 2.67

Cognitive impairment and dementia in neurocysticercosis: a cross-sectional controlled study. Neurology (2010) 2.66

Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med (2006) 2.42

Treatment of neurocysticercosis: current status and future research needs. Neurology (2006) 2.41

Etiology and management of single small CT lesions in patients with seizures: understanding a controversy. Acta Neurol Scand (1991) 2.05

Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology (2005) 2.04

Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol (1990) 2.02

Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg (1990) 1.88

Taeniasis and cysticercosis due to Taenia solium. Prog Clin Parasitol (1994) 1.66

Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia (2005) 1.65

Cysticercotic encephalitis: a severe form in young females. Am J Trop Med Hyg (1987) 1.58

Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med (2001) 1.56

Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect Immun (2004) 1.56

Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial. Pediatr Infect Dis J (2009) 1.45

Neurocysticercosis: treatment with albendazole and dextrochloropheniramine. Trans R Soc Trop Med Hyg (1990) 1.45

Surgical management of neurocysticercosis. Int J Surg (2010) 1.44

Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. Neurology (2005) 1.43

Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú. Neurology (1999) 1.42

Effective, single-dose treatment or porcine cysticercosis with oxfendazole. Am J Trop Med Hyg (1996) 1.37

Cysticercosis and neurocysticercosis as pathogens affecting the nervous system. Prog Neurobiol (2009) 1.33

Time-response curve of oxfendazole in the treatment of swine cysticercosis. Am J Trop Med Hyg (1998) 1.33

Vaccination of pigs to control human neurocysticercosis. Am J Trop Med Hyg (2005) 1.32

Endoscopic management of hydrocephalus due to neurocysticercosis. Clin Neurol Neurosurg (2009) 1.30

Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther (2011) 1.28

Neurocysticercosis: unraveling the nature of the single cysticercal granuloma. Neurology (2010) 1.27

Plasma levels of praziquantel decrease when dexamethasone is given simultaneously. Neurology (1987) 1.25

Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. Br J Clin Pharmacol (2011) 1.13

[Therapeutic efficacy of praziquantel, albendazole and a combination of the two drugs in cysticercosis]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (2003) 1.06

Reduction in rate of epilepsy from neurocysticercosis by community interventions: the Salamá, Honduras study. Epilepsia (2011) 1.01

A prognostic classification of cerebral cysticercosis: therapeutic implications. J Neurol Neurosurg Psychiatry (1986) 0.98

Single-day praziquantel therapy for neurocysticercosis. N Engl J Med (1996) 0.97

Neurocysticercosis and its impact on crude prevalence rate of epilepsy in an Indian community. Neurol India (2011) 0.97

Circulating parasite antigen in patients with hydrocephalus secondary to neurocysticercosis. Am J Trop Med Hyg (2002) 0.96

Experimental infection model for Taenia solium cysticercosis in swine. Cysticercosis Working Group in Peru. Vet Parasitol (2000) 0.85

Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study. J Neurosurg (1996) 0.81

Articles by these authors

Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis (2003) 15.02

Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med (2006) 8.39

Taenia solium cysticercosis. Lancet (2003) 5.89

A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med (2004) 5.75

Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA (2007) 5.22

Human brucellosis. Lancet Infect Dis (2007) 4.92

Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet (2002) 4.90

Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol (2008) 4.46

Effect of water and sanitation on childhood health in a poor Peruvian peri-urban community. Lancet (2004) 4.36

Natural ventilation for the prevention of airborne contagion. PLoS Med (2007) 3.73

The effect of deforestation on the human-biting rate of Anopheles darlingi, the primary vector of Falciparum malaria in the Peruvian Amazon. Am J Trop Med Hyg (2006) 3.72

Prevention and control of cystic echinococcosis. Lancet Infect Dis (2007) 3.64

Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev (2002) 3.37

Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol (2004) 3.27

Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science (2004) 3.06

Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol (2008) 3.04

Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis (2005) 2.75

Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study. Lancet Infect Dis (2010) 2.69

Linking deforestation to malaria in the Amazon: characterization of the breeding habitat of the principal malaria vector, Anopheles darlingi. Am J Trop Med Hyg (2009) 2.64

Triosephosphate isomerase gene characterization and potential zoonotic transmission of Giardia duodenalis. Emerg Infect Dis (2003) 2.46

Endemic malaria in the Peruvian Amazon region of Iquitos. Am J Trop Med Hyg (2003) 2.43

Species identification after treatment for human taeniasis. Lancet (2004) 2.43

Multiple norovirus infections in a birth cohort in a Peruvian Periurban community. Clin Infect Dis (2013) 2.37

The detection of airborne transmission of tuberculosis from HIV-infected patients, using an in vivo air sampling model. Clin Infect Dis (2007) 2.28

Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy. Clin Infect Dis (2010) 2.11

Neurocysticercosis: A natural human model of epileptogenesis. Epilepsia (2014) 2.11

New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg (2005) 2.10

The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med (2008) 2.08

Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis (2009) 2.06

Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg (2006) 2.05

Can the power of mobile phones be used to improve tuberculosis diagnosis in developing countries? Trans R Soc Trop Med Hyg (2008) 2.01

Environmental exposure and leptospirosis, Peru. Emerg Infect Dis (2004) 1.96

Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis (2008) 1.96

Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe (2009) 1.96

Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med (2006) 1.92

Effects of acute diarrhea on linear growth in Peruvian children. Am J Epidemiol (2003) 1.90

Human leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon. PLoS Negl Trop Dis (2008) 1.87

Periurban Trypanosoma cruzi-infected Triatoma infestans, Arequipa, Peru. Emerg Infect Dis (2006) 1.85

Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis (2009) 1.81

Improved recovery of Mycobacterium tuberculosis from children using the microscopic observation drug susceptibility method. Pediatrics (2006) 1.74

Fecal contamination of drinking water within peri-urban households, Lima, Peru. Am J Trop Med Hyg (2007) 1.72

Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia (2005) 1.65

Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission. PLoS Med (2009) 1.64

Transposable element ISHp608 of Helicobacter pylori: nonrandom geographic distribution, functional organization, and insertion specificity. J Bacteriol (2002) 1.60

Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. J Infect Dis (2004) 1.60

Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart (2011) 1.60

Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons. Clin Infect Dis (2010) 1.60

Diagnosis of sputum-scarce HIV-associated pulmonary tuberculosis in Lima, Peru. Lancet (2005) 1.57

Hyperendemic human and porcine Taenia solium infection in Perú. Am J Trop Med Hyg (2003) 1.56

Improved detection of Mycobacterium tuberculosis in Peruvian children by use of a heminested IS6110 polymerase chain reaction assay. Clin Infect Dis (2002) 1.56

Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis (2009) 1.55

Swine cysticercosis hotspots surrounding Taenia solium tapeworm carriers. Am J Trop Med Hyg (2007) 1.54

Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons. J Infect Dis (2007) 1.53

Utility of a protein fraction with cathepsin L-Like activity purified from cysticercus fluid of Taenia solium in the diagnosis of human cysticercosis. Am J Trop Med Hyg (2009) 1.53

Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open (2012) 1.52

Helicobacter Pylori's plasticity zones are novel transposable elements. PLoS One (2009) 1.48

Helicobacter pylori from Peruvian amerindians: traces of human migrations in strains from remote Amazon, and genome sequence of an Amerind strain. PLoS One (2010) 1.48

The effect on cardiovascular risk factors of migration from rural to urban areas in Peru: PERU MIGRANT Study. BMC Cardiovasc Disord (2009) 1.46

Lung ultrasound for the diagnosis of pneumonia in adults: a systematic review and meta-analysis. Respir Res (2014) 1.44

Epidemiologic differences between cyclosporiasis and cryptosporidiosis in Peruvian children. Emerg Infect Dis (2002) 1.43

Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis. J Clin Microbiol (2002) 1.43

Socio-demographics and the development of malaria elimination strategies in the low transmission setting. Acta Trop (2011) 1.43

Chagas disease transmission in periurban communities of Arequipa, Peru. Clin Infect Dis (2008) 1.40

Effects of nutritional status on diarrhea in Peruvian children. J Pediatr (2002) 1.39

Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection. Am J Trop Med Hyg (2009) 1.38

Human caliciviruses as a cause of severe gastroenteritis in Peruvian children. J Infect Dis (2004) 1.37

Identification of the cryptosporidium pig genotype in a human patient. J Infect Dis (2002) 1.36

Cryptosporidium species and genotypes in HIV-positive patients in Lima, Peru. J Eukaryot Microbiol (2003) 1.34

The epidemiology of intestinal microsporidiosis in patients with HIV/AIDS in Lima, Peru. J Infect Dis (2005) 1.33

Diversity of bat-associated Leptospira in the Peruvian Amazon inferred by bayesian phylogenetic analysis of 16S ribosomal DNA sequences. Am J Trop Med Hyg (2005) 1.33

Wasting is associated with stunting in early childhood. J Nutr (2012) 1.33

Vaccination of pigs to control human neurocysticercosis. Am J Trop Med Hyg (2005) 1.32

Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-alpha-dependent monocyte networks. J Immunol (2003) 1.30

Impregnated netting slows infestation by Triatoma infestans. Am J Trop Med Hyg (2008) 1.29

Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis. Clin Vaccine Immunol (2009) 1.29

Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb) (2009) 1.29

Seroepidemiology of strongyloidiasis in the Peruvian Amazon. Am J Trop Med Hyg (2006) 1.28

Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis. Mol Biochem Parasitol (2006) 1.28

Cluster of type IV secretion genes in Helicobacter pylori's plasticity zone. J Bacteriol (2003) 1.26

Targeted screening strategies to detect Trypanosoma cruzi infection in children. PLoS Negl Trop Dis (2007) 1.26

Infrequent MODS TB culture cross-contamination in a high-burden resource-poor setting. Diagn Microbiol Infect Dis (2006) 1.26

Lack of an adverse effect of Giardia intestinalis infection on the health of Peruvian children. Am J Epidemiol (2008) 1.24

Systems biology approach predicts antibody signature associated with Brucella melitensis infection in humans. J Proteome Res (2011) 1.24

Diagnosis of cystic echinococcosis, central Peruvian Highlands. Emerg Infect Dis (2008) 1.23

Diarrhea in early childhood: short-term association with weight and long-term association with length. Am J Epidemiol (2013) 1.22

Evaluation of brucellosis by PCR and persistence after treatment in patients returning to the hospital for follow-up. Am J Trop Med Hyg (2007) 1.22